Julie Louise Gerberding
Dr. Julie L. Gerberding, MD, is an Independent Director at Cerner Corp., a Chief Patient Officer & EVP-Communication at Merck & Co., Inc. and a Member at Institute of Medicine. She is on the Board of Directors at Cerner Corp., Accordia Global Health Foundation, Biotechnology Innovation Organization, MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. and Case Western Reserve University. Dr. Gerberding was previously employed as a President by Merck Vaccine Division, a Co-Chairman by MSD Vaccines Ltd., and a Director-Emeritus by Project HOPE-The-People-To-People HealthFoundation, Inc. She also served on the board at Centers for Disease Control & Prevention. She received her undergraduate degree from Case Western Reserve University, a graduate degree from the University of California, Berkeley and a doctorate degree from Case Western Reserve University.
|05/22/2020||3,716||Award at $0 per share.||0|
|08/22/2019||7,928||Disposition at $71.82 per share.||569,389|
|05/30/2019||3,556||Award at $0 per share.||0|
|05/18/2018||4,100||Award at $0 per share.||0|
|05/24/2017||3,900||Award at $0 per share.||0|
|03/03/2017||4,500||Award at $0 per share.||0|